In brief, APOC3 variants (C-482T or T-455C) in the promoter are reported to predispose subjects to NAFLD by Petersen et al. [32], but this observation was disproved by Kozlitina et al. [41]. This evidence concerns the gene APOC3 and metabolic dysfunction-associated steatotic liver disease.